These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17054236)

  • 1. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Al-Inany HG; Farquhar CM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Houston B; Al-Inany HG; Farquhar C
    Cochrane Database Syst Rev; 2013 Jan; (1):CD005072. PubMed ID: 23440798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Gibbons T; Georgiou EX; Cheong YC; Wise MR
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD005072. PubMed ID: 34928503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
    Song SY; Park M; Lee GW; Lee KH; Chang HK; Kwak SM; Yoo HJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():85-92. PubMed ID: 30336309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery versus medical therapy for heavy menstrual bleeding.
    Marjoribanks J; Lethaby A; Farquhar C
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
    Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
    J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence.
    Cho S; Jung JA; Lee Y; Kim HY; Seo SK; Choi YS; Lee JS; Lee BS
    Acta Obstet Gynecol Scand; 2014 Jan; 93(1):38-44. PubMed ID: 24605384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
    Anpalagan A; Condous G
    J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study.
    Kim MK; Chon SJ; Lee JH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
    Reprod Sci; 2018 Jan; 25(1):39-43. PubMed ID: 28683602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
    Christelle K; Norhayati MN; Jaafar SH
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006034. PubMed ID: 36017945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
    Wan YL; Holland C
    Climacteric; 2011 Dec; 14(6):622-32. PubMed ID: 22017273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.